Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results
This article was originally published in The Rose Sheet
Executive Summary
FDA's draft guidance for labeling of alpha hydroxy acid-containing products is an interim step taken while the agency continues to evaluate AHAs and their impact on increased skin sensitivity to the sun, FDA says in a Dec. 2 1Federal Register notice